Patents by Inventor Patrice D. Cani

Patrice D. Cani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION FOR REDUCING BODY FAT
    Publication number: 20160287649
    Abstract: The present invention relates to a pharmaceutical composition comprising, as active substance, Saccharomyces boulardii yeast cells, for use for reducing body fat in an individual.
    Type: Application
    Filed: November 7, 2014
    Publication date: October 6, 2016
    Inventors: Patrice D. CANI, Amandine EVERARD, Lucie GEURTS, Emilie FARGIER, Marc VERLEYE, Marie-Emmanuelle LE GUERN
  • Arabinoxylans for modulating the barrier function of the intestinal surface
    Patent number: 8465788
    Abstract: The present invention is directed to a particular arabinoxylan (“AX”) preparation and the finding that this preparation has a beneficial effect on the organization of the intestinal microbial community in the lumen and in particular at the site of the gut mucosa, where it modulates the barrier function of the intestinal surface, primarily by modulating the mucosa-associated microbial community towards a relative increase of health beneficial bacteria, such as bifidobacteria and lactobacilli. It is accordingly a first aspect of the present invention to provide said arabinoxylan preparation characterized in comprising isolated water-soluble arabinoxylans and the use thereof to improve functioning (e.g. barrier function) of the intestinal epithelium.
    Type: Grant
    Filed: August 18, 2009
    Date of Patent: June 18, 2013
    Assignee: BioActor B.V.
    Inventors: Peter Frank Ekhart, Hans Van Der Saag, Sam Possemiers, Pieter Van Den Abbeele, Tom Van De Wiele, Audrey Martine Neyrinck, Nathalie Maria Nelly Delzenne, Patrice D Cani
  • ARABINOXYLANS FOR MODULATING THE BARRIER FUNCTION OF THE INTESTINAL SURFACE
    Publication number: 20120230955
    Abstract: The present invention is directed to a particular arabinoxylan (“AX”) preparation and the finding that this preparation has a beneficial effect on the organization of the intestinal microbial community in the lumen and in particular at the site of the gut mucosa, where it modulates the barrier function of the intestinal surface, primarily by modulating the mucosa-associated microbial community towards a relative increase of health beneficial bacteria, such as bifidobacteria and lactobacilli. It is accordingly a first aspect of the present invention to provide said arabinoxylan preparation characterized in comprising isolated water-soluble arabinoxylans and the use thereof to improve functioning (e.g. barrier function) of the intestinal epithelium.
    Type: Application
    Filed: August 18, 2009
    Publication date: September 13, 2012
    Applicant: BioActor bvba
    Inventors: Peter Frank Ekhart, Hans Van De Saag, Sam Possemiers, Pieter Van Den Abbeele, Tom Van De Wiele, Audrey Martine Neyrinck, Nathalie Maria Nelly Delzenne, Patrice D. Cani